Samsung Electronics' medical device division and Samsung Medison Co. said on the 10th that they will participate in WHX Dubai 2026, the Middle East's largest medical exhibition, held in Dubai from the 9th to the 12th.
Samsung will launch the new ultrasound products V4 and EVO Q10 globally at this exhibition and will unveil the radiology-dedicated premium ultrasound diagnostic system R20 in the Middle East for the first time.
The new V4 is a next-generation ultrasound system designed on Intel's latest NPU. By integrating and optimizing circuits and mechanical structures, it improved completeness, and by maximizing power efficiency, it reduced power consumption by 35% compared with previous models. It also applies various AI features while maintaining high resolution.
In particular, V4 is the world's first to adopt a fanless design, enabling high-performance computing and stable thermal control without a cooling fan. With no external fan, dust does not enter the device, and it provides a zero dB exam environment with no fan noise.
EVO Q10 is a laptop-style product that enhances the portability of V4. With high-resolution images and AI features, it enables accurate and swift diagnoses in emergency, outpatient, and mobile care settings. The company said its light and robust housing design, minimized protrusions, and IP22 water resistance certification also improve ease of disinfection and maintenance.
At the launch event, AI diagnostic assistance features, including screen mirroring and HeartAssist™, an automatic heart recognition function, will also be demonstrated.
Beyond ultrasound, Samsung will showcase X-ray technology innovations by unveiling GC85 Vision+, which lowers radiation dose and improves exam efficiency, and GM85, which verifies the imaging area in real time. It will also exhibit the F3025-AW, a high-resolution, high-performance, 1.5 kg lightweight glass-free detector capable of expressing fine structures such as those in infants and young children.
On the third day of the exhibition, the Samsung AI Symposium will be held. Vito Cantisani, vice chair of radiology at Sapienza University of Rome, will share clinical use cases of Samsung's AI diagnostic assistance in liver and abdominal diagnostics. Hisham Mirghani, a world-renowned obstetrician-gynecologist, is scheduled to conduct a live scan using the premium ultrasound diagnostic system HERA Z20.
Centering on the newly established Middle East and Africa organization in the second half of 2025, Samsung plans to expand cooperation with hospitals, government agencies, local partners, and distributors during the exhibition and seek business opportunities.
Yu Kyu-tae, head of Samsung Electronics' medical device division and CEO of Samsung Medison Co., said, "The Middle East is a key strategic market for Samsung's medical device business," adding, "With diagnostic solutions based on advanced AI technology, our goal at this exhibition is to strengthen the competitiveness of local medical partners and achieve meaningful growth."